What does the nation’s leading medical research agency have to say about CBD and SARS-Cov-2?
According to the National Institute of Health (NIH), CBD inhibits COVID 19 infection because of the antiviral properties that CBD has, making the cells ability to proliferate difficult (Nguyen, et. al., 2021).
The study then went on to state that CBD and its metabolite, 7-OH-CBD, blocks COVID 19 from replicating inside the lungs tissues and reduces the transmission rate (Nguyen, 2021).
Nguyen, et. al., (2021) stated that a cohort study showed that patients who take CBD have a lower number of SARS-CoV-2 infection rates (Nguyen, et. al., 2021).
The NIH concluded the study stating that CBD has the potential to be an antiviral agent at the early stages of infection of the SARS-CoV-2 virus and stated that CBD could be a potential treatment against new pathogenic viruses due to its antiviral properties (Nguyen, et. al., 2021).
God’s universal herbal medicine. I mean, not even science has seen anything with such a broad range of therapeutic uses. To say this plant is fantastic is such an understatement.
*This information is for educational purposes only and simply sharing of the information pertained to this study. No medical advice or claims are being made.
Reference
Nguyen, L. C., Yang, D., Nicolaescu, V., Best, T. J., Ohtsuki, T., Chen, S. N., Friesen, J. B., Drayman, N., Mohamed, A., Dann, C., Silva, D., Gula, H., Jones, K. A., Millis, J. M., Dickinson, B. C., Tay, S., Oakes, S. A., Pauli, G. F., Meltzer, D. O., Randall, G., … Rosner, M. R. (2021). Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response. bioRxiv : the preprint server for biology, 2021.03.10.432967. https://doi.org/10.1101/2021.03.10.432967
